We report a case-series of COVID-19 patients with pulmonary embolism (PE) in our institution. Lille University Hospital is the tertiary care center for the North-of-France, the 2nd French region in population density (189 p/km2), also considered as a “metabolic” area with high number of overweight patients. The study was approved by the Institutional data protection authority of Lille University Hospital…
L’attuale grave epidemia, o forse pandemia, del nuovo coronavirus COVID-19 emerso in Cina a Wuhan alla fine del 2019 ha dimostrato di avere un devastante impatto planetario di salute pubblica. Le implicazioni cardiologiche del coronavirus COVID-19 sono tutt’altro che marginali e costituiscono l’occasione per richiamare l’attenzione del cardiologo sulle rilevanti interazioni tra infezioni da virus respiratori o altri agenti patogeni e rischio cardiovascolare…
The present COVID-19 outbreak emphasizes the need for greater awareness of the immediate and long-term cardiovascular implications of viral infection and the significant gaps in knowledge that future research will need to address…
A relatively high mortality of severe coronavirus disease 2019 (COVID‐19) is worrying, and the application of heparin in COVID‐19 has been recommended by some expert consensus because of the risk of disseminated intravascular coagulation and venous thromboembolism. However, its efficacy remains to be validated…
Si riprendono le attività: come tutelare noi stessi ed i nostri Pazienti in caso di visita medica od esame diagnostico? Abbiamo imparato dalle nostre stesse esperienze che quasi sin da subito il criterio epidemiologico ha perso ogni significato al fine di individuare persone che fossero state esposte al contagio da Coronavirus…